This study indicates that to control BCR/ABL fusion gene expression at the posttranscription level by gene targeting can prevent the malignant transformation of CML.

• 研究结果说明 ；在转录后期 m RNA水平控制 BCR/ABL融合基因的表达可以抑制慢性粒细胞白血病的恶性转化 .